Piramal Pharma Settles Dispute with VetDC Inc for USD 407,400
By Rediff Money Desk, New Delhi Dec 06, 2024 18:07
Piramal Pharma has agreed to pay USD 407,400 to VetDC, Inc to settle a dispute over rejected batches of a product. The company says the settlement will not significantly impact its financial position.
![Piramal Pharma Settles Dispute with VetDC Inc for USD 407,400](https://im.rediff.com/money/2014/apr/11piramal1.jpg?fr=money)
New Delhi, Dec 6 (PTI) Piramal Pharma on Friday said it will pay USD 407,400 to US-based VetDC, Inc to settle a dispute over rejected batches of a product.
Piramal Pharma Solutions Inc, a unit of the company, and VetDC, Inc have entered into a settlement agreement for an amount of USD 407,400, the drug maker said in a regulatory filing.
VetDC had claimed damages on account of rejection of certain batches of product manufactured and supplied by Piramal Pharma Solutions Inc.
"While the company continues to believe that its legal stand is appropriate against claims made by VetDC and maintains that it has defence to VetDC's claims of liabilities and damages, in order to solely avoid continued legal costs and uncertainties of protracted litigation, the Company and VetDC have both decided to settle," Piramal Pharma said.
The company shall have no responsibility for any other costs beyond the amount of USD 407,400, it added.
"This settlement will not have a significant impact on the financial position of the company," Piramal Pharma stated.
Shares of Piramal Pharma on Friday closed 2.59 per cent down at Rs 267 apiece on BSE.
Piramal Pharma Solutions Inc, a unit of the company, and VetDC, Inc have entered into a settlement agreement for an amount of USD 407,400, the drug maker said in a regulatory filing.
VetDC had claimed damages on account of rejection of certain batches of product manufactured and supplied by Piramal Pharma Solutions Inc.
"While the company continues to believe that its legal stand is appropriate against claims made by VetDC and maintains that it has defence to VetDC's claims of liabilities and damages, in order to solely avoid continued legal costs and uncertainties of protracted litigation, the Company and VetDC have both decided to settle," Piramal Pharma said.
The company shall have no responsibility for any other costs beyond the amount of USD 407,400, it added.
"This settlement will not have a significant impact on the financial position of the company," Piramal Pharma stated.
Shares of Piramal Pharma on Friday closed 2.59 per cent down at Rs 267 apiece on BSE.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 7.77 (+ 0.26)
- 41602344
- Srestha Finvest
- 0.70 ( -4.11)
- 20431534
- G G Engineering
- 1.39 (+ 3.73)
- 13055002
- GTL Infrastructure
- 1.81 ( -4.74)
- 11717240
- YES Bank Ltd.
- 17.36 ( -3.39)
- 11212338
MORE NEWS
![PE Investment in...](https://im.rediff.com/80-80/getahead/2024/feb/14real-estate-investment.jpg)
PE Investment in Indian Real Estate Rises 6% in...
Private equity investment in Indian real estate surged to USD 2.82 billion in Apr-Dec...
![India Fintech...](https://im.rediff.com/80-80/money/2023/oct/fintech-1-o.jpg)
India Fintech Funding: 3rd Globally, Down 33%...
Despite a 33% decline, India remained the 3rd largest recipient of fintech funding...
![Laxmi Dental IPO...](https://im.rediff.com/80-80/money/2017/jan/16bse2.jpg)
Laxmi Dental IPO Fully Subscribed in Minutes
Laxmi Dental's IPO was fully subscribed within minutes of opening on Monday, with...